Cortechs.ai | Dementia Imaging: Case-based PET/MRI Approach

Dementia Imaging: Case-based PET/MRI Approach

Cortechs.ai | Dementia Imaging: Case-based PET/MRI Approach

Join us for a webinar that will unlock the latest insights in dementia imaging!

Wednesday, December 17th @ 1:00 PM EST

Dr. Ana M. Franceschi, MD PhD, a leading expert in molecular neuroimaging and Director of Dementia Imaging at the Zucker School of Medicine at Hofstra/Northwell and Lenox Hill Hospital, will break down how advanced PET/MRI techniques are transforming early detection and treatment pathways in Alzheimer’s disease and other neurodegenerative disorders. Whether you’re a radiologist, neurologist, or researcher, this session will be packed with valuable, case-based insights on dementia care.

Sign up below:

More Resources

04/10/2026

OnQ Prostate Vendor Validation: From Research to Clinical Adoption

OnQ Prostate delivers consistent, reliable AI-powered prostate MRI insights across vendors, ensuring confident diagnosis and streamlined clinical workflows.

03/20/2026

Quantitative MRI, the McDonald Criteria, and the Future of Multiple Sclerosis Care

MRI is the foundation for diagnosing and monitoring multiple sclerosis (MS)

03/13/2026

Cortechs Cares: Community Impact and Volunteer Efforts in 2025

Cortechs Cares highlights how our team gave back in 2025 through community volunteer efforts, including an Alzheimer’s Walk and holiday toy drive.

03/11/2026

OnQ™ Prostate: Bringing Quantitative MRI to Prostate Imaging

Advancing prostate MRI with quantitative diffusion biomarkers. OnQ™ Prostate brings objective RSI-based insights to support data-driven cancer evaluation.

03/04/2026

Cortechs.ai and Siemens Healthineers Partner to Expand Global Access to NeuroQuant® Technologies

NeuroQuant® Lesion Surveillance will be integrated into the Siemens Healthineers Digital Marketplace to advance quantitative brain imaging worldwide.

02/25/2026

Cortechs.ai Announces MFDS (KFDA) Approval of Global-Leading NeuroQuant® V5 Platform in South Korea

MFDS approves NeuroQuant® V5 in South Korea, expanding AI-driven volumetric neuroimaging and clinical decision support.
Scroll to Top